Case Report
Respiratory Failure due to Possible Donor-Derived Sporothrix schenckii Infection in a Lung Transplant Recipient
Table 1
Description of reported cases of Sporothrix schenckii infection in solid organ transplant recipients.
| Transplanted organ | Timing of infection | Infection location | Geographic location | Therapy |
| Kidney [5] | 4 years after transplant | Cutaneous | Brazil | Amphotericin × 10 days followed by itraconazole |
| Kidney [5] | Less than one year after transplant | Disseminated | Brazil | Itraconazole initially and then amphotericin after relapse followed by itraconazole |
| Kidney [6] | Recurrence of a prior infection 7 years after transplant | Cutaneous, relapsed with osteomyelitis | Italy | Fluconazole initially and at relapse |
| Kidney [7] | <1 year after transplant | Pulmonary | India | Not specified |
| Kidney [8] | 1-2 years after transplant | Renal | India | Died prior to treatment of unrelated cause |
| Kidney [9] | 4 years after transplant | Disseminated, CNS, and bone | USA | Amphotericin |
| Thoracic [10] (unclear if lung, heart, or both) | Unclear | Pulmonary or articular | USA | Itraconazole |
|
|